نمایش پرونده ساده آیتم

dc.contributor.authorShahnazi, M
dc.contributor.authorKhalili, AF
dc.contributor.authorAzimi, S
dc.date.accessioned2018-08-26T08:52:52Z
dc.date.available2018-08-26T08:52:52Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53825
dc.description.abstractBackground: Preterm premature rupture of membrane (PPROM) prior to 37 weeks’ gestation is among the most common obstetrics problems, which is associated with prenatal mortality and several maternal and neonatal complications. History of PPROM is a risk factor for recurrence. Zinc has an important effect on the strength of membranes by affecting collagen [tensile] strength - a substance with immunity mechanism and antioxidant properties. Objectives: This study was conducted to investigate the effect of zinc supplement on the prevention of PPROM and improvement of some pregnancy outcomes in pregnant women with a history of PPROM during the second trimester and the early third trimester. Methods: In this randomized, double-blind, controlled clinical trial, 108 healthy pregnant women (at gestational age of 16 - 30 weeks) with a history of PPROM and singleton pregnancy were selected by convenience sampling method in the Midwifery Clinic of Shahid Akbarabadi hospital in Tehran, Iran, between 2014 and 2015. They were then divided into two groups of placebo and zinc sulfate tablet (40 mg) recipient using randomized block design. In total, 92 subjects completed the study. The frequency of PPROM was regarded as the primary outcome, and frequency of PROM, average gestational age at birth, average birth weight, and average head circumference were considered as the secondary outcomes. The statistical analysis was based on intent-to-treat principle. Results: There was no between-groups difference in terms of demographic and pregnancy specifications. Results showed no significant between-groups (zinc versus placebo recipient) difference (P > 0.05) in terms of the frequency of preterm pregnancy (22% versus 33.3%), frequency of PPROM (4.9% versus 11.8%), frequency of PROM (14.6% versus 17.6%), average birth weight (3192.17 g versus 3080.52 g), average gestational age at birth (38.2 weeks versus 37.2 weeks), and average head circumference at birth (34.63 cm versus 34.81 cm). Conclusions: According to the results, daily intake of zinc sulfate (40 mg) by pregnant women with a history of PPROM does not contribute to the prevention of PPROM and PROM and improvement of average gestational age at birth and anthropometric measurements. © 2016, Iranian Red Crescent Medical Journal.
dc.language.isoEnglish
dc.relation.ispartofIranian Red Crescent Medical Journal
dc.subjectplacebo
dc.subjectzinc sulfate
dc.subjectadult
dc.subjectArticle
dc.subjectbirth weight
dc.subjectcontrolled study
dc.subjectdiet supplementation
dc.subjectdouble blind procedure
dc.subjectfemale
dc.subjectgestational age
dc.subjecthead circumference
dc.subjecthuman
dc.subjectoutcome assessment
dc.subjectpregnancy outcome
dc.subjectpregnant woman
dc.subjectpremature fetus membrane rupture
dc.subjectprematurity
dc.subjectquestionnaire
dc.subjectrandomized controlled trial
dc.titleEffect of zinc supplement on prevention of PPROM and improvement of some pregnancy outcomes in pregnantwomen with a history of PPROM: A randomized double -blind controlled trial
dc.typeArticle
dc.citation.volume19
dc.citation.issue3
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.5812/ircmj.41931


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم